Abstract:Backgrounds: During the Coronavirus Disease 2019 (COVID-19) epidemic, the massive spread of the disease has placed an enormous burden on the world's healthcare and economy. The early risk assessment system based on a variety of machine learning (ML) algorithms may be able to provide more accurate advice on the classification of COVID-19 patients, offering predictive, preventive, and personalized medicine (PPPM) solutions in the future. Methods: In this retrospective study, we divided a portion of the data into training and validation cohorts in a 7:3 ratio and established a model based on a combination of two ML algorithms first. Then, we used another portion of the data as an independent testing cohort to determine the most accurate and stable model and compared it with other scoring systems. Finally, patients were categorized according to risk scores and then the correlation between their clinical data and risk scores was studied. Results: The elderly accounted for the majority of hospitalized patients with COVID-19. The C-index of the model constructed by combining the stepcox[both] and survivalSVM algorithms was 0.840 in the training cohort and 0.815 in the validation cohort, which was calculated to have the highest C-index in the testing cohort compared to the other 119 ML model combinations. Compared with current scoring systems, including the CURB-65 and several reported prognosis models previously, our model had the highest AUC value of 0.778, representing an even higher predictive performance. In addition, the model's AUC values for specific time intervals, including days 7,14 and 28, demonstrate excellent predictive performance. Most importantly, we stratified patients according to the model's risk score and demonstrated a difference in survival status between the high-risk, median-risk, and low-risk groups, which means a new and stable risk assessment system was built. Finally, we found that COVID-19 patients with a history of cerebral infarction had a significantly higher risk of death. Conclusion: This novel risk assessment system is highly accurate in predicting the prognosis of patients with COVID-19, especially elderly patients with COVID-19, and can be well applied within the PPPM framework. Our ML model facilitates stratified patient management, meanwhile promoting the optimal use of healthcare resources.

Machine learning algorithms utilizing blood parameters enable early detection of immunethrombotic dysregulation in COVID‐19

IP-10 and MCP-1 As Biomarkers Predicting Disease Severity of COVID-19

A Prediction Model Based on Machine Learning for Diagnosing the Early COVID-19 Patients

Deep Learning of Dual Plasma Fingerprints for High-Performance Infection Classification.

Accurate COVID-19 Detection Using Full Blood Count Data and Machine Learning

Early Prediction of COVID-19 Patient Survival by Blood Plasma Using Machine Learning

Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study

Early Prediction of Mortality Risk among Patients with Severe COVID-19, Using Machine Learning

Peripheral blood indicators and COVID-19: an observational and bidirectional Mendelian randomization study

Machine learning algorithm approach to complete blood count can be used as early predictor of COVID-19 outcome

Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests

Development of a COVID-19 early risk assessment system based on multiple machine learning algorithms and routine blood tests: a real-world study

Severity Detection for the Coronavirus Disease 2019 (COVID-19) Patients Using a Machine Learning Model Based on the Blood and Urine Tests

Machine learning based early warning system enables accurate mortality risk prediction for COVID-19

Using Machine Learning Methods in Identifying Genes Associated with COVID-19 in Cardiomyocytes and Cardiac Vascular Endothelial Cells.

Early coagulation tests predict risk stratification and prognosis of COVID-19

COVID-19 diagnosis by routine blood tests using machine learning

Machine learning‐driven blood transcriptome‐based discovery of SARS‐CoV‐2 specific severity biomarkers

Development and Validation of a Machine Learning Approach for Automated Severity Assessment of COVID-19 Based on Clinical and Imaging Data: Retrospective Study

Eleven routine clinical features predict COVID-19 severity uncovered by machine learning of longitudinal measurements